1. AINSWORTH, M., ANDERSSON, M., AUCKLAND, K., BAILLIE, J. K., BARNES, E., BEER, S., BEVERIDGE, A., BIBI, S., BLACKWELL, L. et al. (2020). Performance characteristics of five immunoassays for SARS-CoV-2: A head-to-head benchmark comparison. Lancet Infect. Dis. 20 1390–1400.
2. ALTER, G. and SEDER, R. (2020). The power of antibody-based surveillance. N. Engl. J. Med. 383 1782–1784.
3. BARNDORFF-NIELSEN, O. E. (1986). Inference on full or partial parameters based on the standardized signed log likelihood ratio. Biometrika 73 307–322.
4. BENDAVID, E., MULANEY, B., SOOD, N., SHAH, S., LING, E., BROMLEY-DULFANO, R., LAI, C., WEISSBERG, Z., SAAVEDRA, R. et al. (2020a). COVID-19 antibody seroprevalence in Santa Clara County, California. MedRxiv April 11.
5. BENDAVID, E., MULANEY, B., SOOD, N., SHAH, S., LING, E., BROMLEY-DULFANO, R., LAI, C., WEISSBERG, Z., SAAVEDRA, R. et al. (2020b). COVID-19 antibody seroprevalence in Santa Clara County, California. MedRxiv April 27.